Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan
Mad in America
OCTOBER 18, 2023
Listen to the audio of the interview here. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are.
Let's personalize your content